The following tables present a rollforward of deferred policy acquisition costs by reporting segment and disaggregated by product type.


	March 31, 2026
	Aflac Japan								Aflac U.S.
(In millions)	Cancer		Medical and Other Health		Life Insurance		Other		Accident		Disability		Critical Care		Hospital Indemnity		Dental/ Vision		Life Insurance		Other		Total
Deferred policy acquisition costs:
Balance at December 31, 2025	$	2,965	$	1,840	$	446	$	51	$	909	$	641	$	1,355	$	463	$	87	$	277	$	0	$	9,034
Capitalization	80		26		14		0		32		30		37		21		3		29		0		272
Amortization expense	(46)		(23)		(8)		(1)		(37)		(31)		(40)		(21)		(3)		(11)		0		(221)

Foreign currency translation and other	(62)		(38)		(9)		0		0		0		0		0		0		0		0		(109)
Balance at March 31, 2026	$	2,937	$	1,805	$	443	$	50	$	904	$	640	$	1,352	$	463	$	87	$	295	$	0	$	8,976


	December 31, 2025
	Aflac Japan								Aflac U.S.
(In millions)	Cancer		Medical and Other Health		Life Insurance		Other		Accident		Disability		Critical Care		Hospital Indemnity		Dental/ Vision		Life Insurance		Other		Total
Deferred policy acquisition costs:
Balance at December 31, 2024	$	2,776	$	1,833	$	441	$	52	$	915	$	636	$	1,348	$	452	$	86	$	219	$	0	$	8,758
Capitalization	357		85		33		3		137		127		162		90		13		98		0		1,105
Amortization expense	(188)		(99)		(33)		(3)		(143)		(122)		(155)		(79)		(12)		(40)		0		(874)

Foreign currency translation and other	20		21		5		(1)		0		0		0		0		0		0		0		45
Balance at December 31, 2025	$	2,965	$	1,840	$	446	$	51	$	909	$	641	$	1,355	$	463	$	87	$	277	$	0	$	9,034

There were no changes to the inputs, judgments, assumptions or methods used to determine amortization amounts during the three-month periods ended March 31, 2026 and 2025. For additional information on deferred policy acquisition costs, see Notes 1 and 6 of the Notes to the Consolidated Financial Statements in the 2025 Annual Report.